Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immunoprecise Antibodies Ltd (IPA.VN)

Immunoprecise Antibodies Ltd (IPA.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 162,080
  • Shares Outstanding, K 24,935
  • Annual Sales, $ 20,665 K
  • Annual Income, $ -26,560 K
  • 60-Month Beta 0.09
  • Price/Sales 7.04
  • Price/Cash Flow N/A
  • Price/Book 2.45
Trade IPA.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.06
  • Most Recent Earnings $-0.38 on N/A
  • Latest Earnings Date 12/12/22
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.950 +9.24%
on 11/24/22
7.750 -16.13%
on 10/26/22
-0.740 (-10.22%)
since 10/25/22
3-Month
5.200 +25.00%
on 09/30/22
8.000 -18.75%
on 08/26/22
-1.500 (-18.75%)
since 08/25/22
52-Week
4.520 +43.81%
on 03/14/22
8.810 -26.22%
on 11/29/21
-0.960 (-12.87%)
since 11/25/21

Most Recent Stories

More News
ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting from TSX Venture Exchange

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) announces that it has applied and has received approval for a voluntary delisting of its common shares from...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
IPA’s Subsidiary Talem Therapeutics Licenses Antibodies for Three OmniChicken-Derived Programs

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), today announced that its subsidiary, Talem Therapeutics LLC (“Talem”), has entered into a multi-target...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
NIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), announced today that its subsidiary, Talem Therapeutics LLC (“Talem”), has shared positive results of...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, today announced financial results for first quarter...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
Live Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope’s Efficacy Against SARS-CoV-2 Variants Including BA.5

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), a biotherapeutic research and technology company, today announced the continuing success of PolyTope® TATX-03...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2022

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, today announced financial results for the full...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2022 on July 29, 2022

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
Histopathology Data of Preclinical Repeated Dose Toxicity Study and ex vivo Human Tissue Cross-Reactivity (TCR) Analysis Support Safety of IPA’s PolyTope® TATX-03, a Synergistic Antibody Cocktail against SARS‑CoV‑2

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, reports the critical third-party findings of...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)
IPA’s Subsidiary BioStrand Secures Second VLAIO Research Grant

Diepe IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to share that IPA’s subsidiary Biostrand, a Belgian end-to-end multi-omics analysis platform...

IPA : 1.1900 (-2.46%)
IPA.VN : 6.500 (+0.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of...

See More

Key Turning Points

3rd Resistance Point 7.247
2nd Resistance Point 6.973
1st Resistance Point 6.737
Last Price 6.500
1st Support Level 6.227
2nd Support Level 5.953
3rd Support Level 5.717

See More

52-Week High 8.810
Fibonacci 61.8% 7.171
Fibonacci 50% 6.665
Last Price 6.500
Fibonacci 38.2% 6.159
52-Week Low 4.520

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar